US2007299035A1PendingUtilityA1
Use of chemical chelators as reversal agents for drug-induced neuromuscular block
Est. expiryAug 13, 2019(expired)· nominal 20-yr term from priority
A61P 39/04A61P 25/00A61P 25/30A61K 31/194A61K 31/724A61P 21/02A61P 21/00
51
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention relates to the use of chemical chelators for the preparation of a medicament for the reversal of drug-induced neuromuscular block, to a kit for providing neuromuscular block and its reversal, and to cyclophane derivatives having the general formula A wherein R is the general formula B wherein X is or a pharmaceutically acceptable salt thereof.
Claims
exact text as granted — not AI-modified1 - 33 . (canceled)
34 . A method for reversal of drug-induced neuromuscular block in a patient caused by clinically-used neuromuscular blocking agent which acts by reversible binding to the acetylcholine receptor, comprising parenterally administering to said patient an effective amount of a chemical chelator capable of forming a guest-host complex with the neuromuscular blocking agent, wherein the association constant of said guest-host in an aqueous medium at ambient temperature is higher than 10.000 M-1.
35 . The method according to claim 34 , wherein the neuromuscular blocking agent is selected from the group consisting of rocuronium, vecuronium, pancuronium, rapacuronium, mivacurium, (cis)atracurium and tubocurarine.
36 . The method according to claim 34 , wherein the chemical chelator is selected from the group consisting of cyclic oligosaccharides and cyclophanes.
37 . The method according to claim 34 , wherein the chemical chelator is gamma-cyclodextrin or a derivative thereof.
38 . The method according to claim 34 , wherein the neuromuscular blocking agent is selected from the group consisting of rocuronium and vecuronium and the chemical chelator is gamma-cyclodextrin or a derivative thereof.Join the waitlist — get patent alerts
Track US2007299035A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.